CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- 4 Open-market sale Chief Financial Officer sold 1,428 shares at $11.22 ($16,022)
- 4 Open-market sale President and CEO sold 3,195 shares at $11.22 ($35,848)
- 4 Grant or award EVP, Head of R&D acquired 46,250 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award SVP, GC & Secretary acquired 55,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Operations Officer sold 657 shares at $7.94 ($5,217)
- 4 Open-market sale Chief Financial Officer sold 1,827 shares at $9.17 ($16,754)
- 4 Open-market sale Chief Operations Officer sold 2,740 shares at $9.17 ($25,126)
- 4 Grant or award Chief Financial Officer acquired 66,875 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 55,000 shares (grant or award)
- 4 Grant or award Chief Operations Officer acquired 75,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 150,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Tech. Operations Officer sold 4,117 shares at $14.21 ($58,503)
Page 12 of 33 · 645 filings